91 related articles for article (PubMed ID: 20308435)
1. Science to practice: will randomized prospective clinical trials be necessary for RF ablation of large liver tumors with liposomal doxorubicin?
Unger EC
Radiology; 2010 Apr; 255(1):1-2. PubMed ID: 20308435
[No Abstract] [Full Text] [Related]
2. Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways.
Solazzo SA; Ahmed M; Schor-Bardach R; Yang W; Girnun GD; Rahmanuddin S; Levchenko T; Signoretti S; Spitz DR; Torchilin V; Goldberg SN
Radiology; 2010 Apr; 255(1):62-74. PubMed ID: 20160000
[TBL] [Abstract][Full Text] [Related]
3. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time.
Ahmed M; Lukyanov AN; Torchilin V; Tournier H; Schneider AN; Goldberg SN
J Vasc Interv Radiol; 2005 Oct; 16(10):1365-71. PubMed ID: 16221908
[TBL] [Abstract][Full Text] [Related]
4. Effect of thermal dose on heat shock protein expression after radio-frequency ablation with and without adjuvant nanoparticle chemotherapies.
Moussa M; Goldberg SN; Kumar G; Levchenko T; Torchilin V; Ahmed M
Int J Hyperthermia; 2016 Dec; 32(8):829-841. PubMed ID: 27600101
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation.
Ahmed M; Monsky WE; Girnun G; Lukyanov A; D'Ippolito G; Kruskal JB; Stuart KE; Torchilin VP; Goldberg SN
Cancer Res; 2003 Oct; 63(19):6327-33. PubMed ID: 14559820
[TBL] [Abstract][Full Text] [Related]
6. Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model?
Yang W; Ahmed M; Elian M; Hady el-SA; Levchenko TS; Sawant RR; Signoretti S; Collins M; Torchilin VP; Goldberg SN
Radiology; 2010 Dec; 257(3):685-96. PubMed ID: 20858851
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal model.
Yang W; Ahmed M; Tasawwar B; Levchenko T; Sawant RR; Collins M; Signoretti S; Torchilin V; Goldberg SN
Int J Hyperthermia; 2011; 27(6):527-38. PubMed ID: 21846189
[TBL] [Abstract][Full Text] [Related]
8. Combination radiofrequency (RF) ablation and IV liposomal heat shock protein suppression: reduced tumor growth and increased animal endpoint survival in a small animal tumor model.
Yang W; Ahmed M; Tasawwar B; Levchenko T; Sawant RR; Torchilin V; Goldberg SN
J Control Release; 2012 Jun; 160(2):239-44. PubMed ID: 22230341
[TBL] [Abstract][Full Text] [Related]
9. Lyso-thermosensitive liposomal doxorubicin: an adjuvant to increase the cure rate of radiofrequency ablation in liver cancer.
Poon RT; Borys N
Future Oncol; 2011 Aug; 7(8):937-45. PubMed ID: 21823888
[TBL] [Abstract][Full Text] [Related]
10. Radio-frequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model.
Monsky WL; Kruskal JB; Lukyanov AN; Girnun GD; Ahmed M; Gazelle GS; Huertas JC; Stuart KE; Torchilin VP; Goldberg SN
Radiology; 2002 Sep; 224(3):823-9. PubMed ID: 12202721
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous tumor ablation: reduced tumor growth with combined radio-frequency ablation and liposomal doxorubicin in a rat breast tumor model.
D'Ippolito G; Ahmed M; Girnun GD; Stuart KE; Kruskal JB; Halpern EF; Goldberg SN
Radiology; 2003 Jul; 228(1):112-8. PubMed ID: 12808127
[TBL] [Abstract][Full Text] [Related]
12. RF ablation with adjuvant therapy: comparison of external beam radiation and liposomal doxorubicin on ablation efficacy in an animal tumor model.
Solazzo S; Mertyna P; Peddi H; Ahmed M; Horkan C; Goldberg SN
Int J Hyperthermia; 2008 Nov; 24(7):560-7. PubMed ID: 18608584
[TBL] [Abstract][Full Text] [Related]
13. Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer.
Poon RT; Borys N
Expert Opin Pharmacother; 2009 Feb; 10(2):333-43. PubMed ID: 19236203
[TBL] [Abstract][Full Text] [Related]
14. Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals.
Ahmed M; Liu Z; Lukyanov AN; Signoretti S; Horkan C; Monsky WL; Torchilin VP; Goldberg SN
Radiology; 2005 May; 235(2):469-77. PubMed ID: 15858089
[TBL] [Abstract][Full Text] [Related]
15. Combination radiofrequency thermal ablation and adjuvant IV liposomal doxorubicin increases tissue coagulation and intratumoural drug accumulation.
Ahmed M; Goldberg SN
Int J Hyperthermia; 2004 Nov; 20(7):781-802. PubMed ID: 15675672
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study.
Lencioni R; Crocetti L; Petruzzi P; Vignali C; Bozzi E; Della Pina C; Bargellini I; Cioni D; Oliveri F; De Simone P; Bartolozzi C; Brunetto M; Filipponi F
J Hepatol; 2008 Aug; 49(2):217-22. PubMed ID: 18486261
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin hydrochloric increases tumour coagulation and end-point survival in percutaneous microwave ablation of tumours in a VX2 rabbit tumour model.
Song X; Liang M; Zhou W; Ren L; Liu Z; Wang G; Wei Q; Wang S
Int J Hyperthermia; 2016 May; 32(3):265-71. PubMed ID: 26905817
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model.
Goldberg SN; Girnan GD; Lukyanov AN; Ahmed M; Monsky WL; Gazelle GS; Huertas JC; Stuart KE; Jacobs T; Torchillin VP; Halpern EF; Kruskal JB
Radiology; 2002 Mar; 222(3):797-804. PubMed ID: 11867804
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy.
Goldberg SN; Kamel IR; Kruskal JB; Reynolds K; Monsky WL; Stuart KE; Ahmed M; Raptopoulos V
AJR Am J Roentgenol; 2002 Jul; 179(1):93-101. PubMed ID: 12076912
[TBL] [Abstract][Full Text] [Related]
20. Pre-, peri-, and postoperative chemotherapy for breast cancer: is one better than the other?
Murthy MS; Scanlon EF; Reid SE; Yang XF
J Surg Oncol; 1996 Apr; 61(4):273-7. PubMed ID: 8627997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
